Insider Trading February 9, 2026

Ensign Group Director Sells $74,250 of Stock as Shares Trade Near Yearly High

Board member Ann Scott Blouin disposed of 375 shares under a scheduled plan while Ensign posts mixed Q4 results and a raised price target

By Avery Klein ENSG
Ensign Group Director Sells $74,250 of Stock as Shares Trade Near Yearly High
ENSG

Ensign Group director Ann Scott Blouin sold 375 shares on February 9, 2026, for $198 each, netting $74,250. The transaction was made under a Rule 10b5-1 plan adopted November 7, 2025. The company recently reported fourth-quarter 2025 results that beat adjusted EPS estimates but slightly missed on revenue, and an analyst raised the price target while keeping a Hold rating.

Key Points

  • Director Ann Scott Blouin sold 375 Ensign Group shares on February 9, 2026, at $198 each, totaling $74,250.
  • The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on November 7, 2025; Blouin now directly owns 22,852 shares.
  • Ensign reported Q4 2025 adjusted EPS of $1.82 versus a $1.75 forecast, with revenue of $1.36 billion slightly under the $1.37 billion estimate; Truist raised its price target from $200 to $215 but kept a Hold rating.

Ann Scott Blouin, a director at The Ensign Group (NASDAQ:ENSG), executed a sale of 375 common shares on February 9, 2026, at a price of $198 per share. The sale generated $74,250 in proceeds and was carried out under a Rule 10b5-1 trading plan that Blouin adopted on November 7, 2025.

Following this disposition, Blouin holds 22,852 shares of Ensign Group directly. At the time of the trade, Ensign shares were trading close to their 52-week high of $202.78, and the stock has returned 52.38% over the past 12 months.

On valuation and financial metrics, Ensign Group carries a market capitalization of $11.49 billion. InvestingPro metrics give the company a "GREAT" financial health score of 3.03, while its price-to-earnings ratio stands at 34.41. InvestingPro data also notes that Ensign has increased its dividend for 19 consecutive years, though the service's current analysis indicates the shares may be trading above their Fair Value.


Recent operating results for the company include fourth-quarter 2025 adjusted earnings per share of $1.82, which exceeded the consensus forecast of $1.75. Revenue for the quarter was $1.36 billion, marginally below the projected $1.37 billion.

In response to the quarter, Truist Securities raised its price objective for The Ensign Group from $200 to $215 while retaining a Hold rating. The firm cited the company’s strong margins and bottom-line performance as factors behind the price-target adjustment.

These developments - an insider sale under a pre-set trading plan, a recent earnings beat on an adjusted EPS basis paired with a slim revenue miss, and an analyst price-target increase that accompanies a Hold rating - mark a notable stretch of activity around Ensign. Investors seeking deeper analysis are referred to the company’s detailed Pro Research Report for further information on financial position and growth prospects.

Risks

  • Valuation concern - InvestingPro’s analysis suggests the stock may be trading above its Fair Value, which could affect market returns for equity investors in the healthcare sector.
  • Revenue shortfall - The slight miss on Q4 2025 revenue versus expectations introduces uncertainty around near-term top-line momentum for the company and could influence healthcare services market perceptions.
  • Insider activity interpretation - While the sale was made under a pre-established Rule 10b5-1 plan, insider sales can be viewed variably by market participants and may affect investor sentiment toward the stock in the healthcare and broader equity markets.

More from Insider Trading

Clean Harbors Director Executes $204,802 Sale as Company Reports Strong Q4 and Pushes M&A Agenda Feb 21, 2026 Clean Harbors Executive Disposes Nearly $1.0M in Stock as Company Posts Strong Q4 Feb 21, 2026 Clean Harbors CFO Disposes $784K in Shares as Company Reports Strong Quarter and Pursues Acquisition Feb 21, 2026 Travelers Executive Vice President Records $1.74 Million Share Sale as Company Posts Strong Quarter Feb 21, 2026 Genasys Director Buys $50,404 of Stock; Company Reports Mixed Q1 Results Feb 21, 2026